HOME Top Market Reports Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021

Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: February 2017
Report Code: BT 4419

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The Regenerative medicine market is expected to reach USD 38.70 Billion by 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6%.

The global market is broadly classified into types, therapy, application and regions. Based on types, the market is segmented into cell-based products and acellular products. The cell-based products is expected to dominate the global market in 2016.Based on therapy, the market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. Immunotherapy is the fastest growing segment in the global market, during the forecast period.

This market is also segmented by application. By application, the segments are orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications.  Oncology is the fastest growing application market in the global market in 2016.

By region, the Regenerative medicine market is segmented into North America, Europe, Asia-Pacific and Rest of the world (RoW). Asia-Pacific is the fastest growing segment in the global market, during the forecast period.

The key players in the cell-based products segment are Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.). The key players in the acellular products segment are Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).

Target Audience for this Report:

  • Healthcare providers & clinical experts
  • Service providers
  • Therapeutic companies
  • Contract manufacturers
  • Academic research institutes

Value Addition for the Buyer:

This report aims to provide insights into the global Regenerative medicine market. It provides valuable information on the types, therapy, application, and regions in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

The above-mentioned information would benefit the buyer by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize the growth opportunities.

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

This report categorizes the Regenerative medicine market into the following segments:

Regenerative medicine Market, by Type

  • Cell-based products
  • Acellular products

Regenerative medicine Market, by Therapy

  • Cell Therapy
  • Gene Therapy
  • Tissue Engineering
  • Immunotherapy

Regenerative medicine Market, by Application

  • Orthopedic & Musculoskeletal Disorders
  • Dermatology
  • Cardiology
  • Diabetes
  • Central Nervous System Diseases
  • Other Applications (ocular, autoimmune, dental/oral, and rare diseases)

Regenerative medicine Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • RoE
  • Asia-Pacific
  • Rest of the World (RoW)

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

Table of Contents

1 Introduction (Page No. - 12)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 15)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Market Share Estimation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Assumptions for the Study

3 Executive Summary (Page No. - 22)

4 Premium Insights (Page No. - 25)
    4.1 Regenerative Medicine: Market Overview
    4.2 Geographic Analysis: Regenerative Medicine Market, By Therapy, 2016
    4.3 Geographical Snapshot of the Regenerative Medicine Market

5 Market Overview (Page No. - 28)
    5.1 Introduction
    5.2 Market Dynamics
    5.3 Drivers
           5.3.1 Government & Private Funding to Support the Development of Regenerative Medicine
           5.3.2 Rising Prevalence of Chronic Diseases and Genetic Disorders
           5.3.3 Increase in Global Healthcare Expenditure
           5.3.4 Rapid Growth in the Aging Population
           5.3.5 Increase in Corporate Partnerships to Accelerate Development and Commercialization of Regenerative Medicine
    5.4 Restraints
           5.4.1 Ethical Concerns With the Use of Embryonic Stem Cell for R&D
           5.4.2 Lack of Clear Regulatory Guidelines
    5.5 Opportunities
           5.5.1 Rising Demand for Organ Transplantation
           5.5.2 Strong Product Pipeline

6 Global Regenerative Medicine Market, By Product (Page No. - 36)
    6.1 Introduction
    6.2 Cell-Based Products
           6.2.1 Allogeneic Products
           6.2.2 Autologous Products
    6.3 Acellular Products

7 Global Regenerative Medicine Market, By Therapy (Page No. - 44)
    7.1 Introduction
    7.2 Cell Therapy
    7.3 Tissue Engineering
    7.4 Immunotherapy
    7.5 Gene Therapy

8 Regenerative Medicine Market, By Application (Page No. - 52)
    8.1 Introduction
    8.2 Orthopedic & Musculoskeletal Disorders
    8.3 Dermatology
    8.4 Cardiology
    8.5 Central Nervous System Diseases
    8.6 Oncology
    8.7 Diabetes
    8.8 Other Applications

9 Global Regenerative Medicine Market, By Region (Page No. - 63)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 U.K.
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe (RoE)
    9.4 Asia-Pacific
    9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. - 102)
     10.1 Overview
     10.2 Market Ranking
     10.3 Competitive Situation and Trends
               10.3.1 Acquisitions
               10.3.2 Partnerships
               10.3.3 Regulatory Approvals
               10.3.4 New Product Developments
               10.3.5 Others

11 Company Profiles (Page No. - 111)
(Overview, Financial*, Products & Services, Strategy, and Developments)
     11.1 Acelity L.P. Inc. (KCI Licensing)
     11.2 Nuvasive, Inc.
     11.3 Vericel Corporation
     11.4 Osiris Therapeutics, Inc.
     11.5 Integra Lifesciences Corporation
     11.6 Stryker Corporation
     11.7 Medtronic PLC 
     11.8 Cook Biotech Incorporated
     11.9 Organogenesis Inc.
     11.10 Japan Tissue Engineering Co., Ltd. (Subsidiary of Fujifilm Holdings Corporation)

*Details Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 130)
     12.1 Insights From Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details


List of Tables (87 Tables)

Table 1 Key Corporate Partnerships, 2016
Table 2 Gene Therapy Products in Clinical Trials, 2016
Table 3 Cell and Gene Therapy Clinical Product Pipeline, 2016
Table 4 Global Market Size, By Product, 2014–2021 (USD Billion)
Table 5 Cell-Based Products Market Size, By Region, 2014–2021 (USD Billion)
Table 6 Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 7 Allogeneic Products Market Size, By Region, 2014–2021 (USD Billion)
Table 8 Autologous Products Market Size, By Region, 2014–2021 (USD Billion)
Table 9 Acellular Products Market Size, By Region, 2014–2021 (USD Billion)
Table 10 Global Market Size, By Therapy, 2014–2021 (USD Billion)
Table 11 Stem Cell Therapies in Phase Iii Development, 2016
Table 12 Cell Therapy Market Size, By Region, 2014-2021 (USD Billion)
Table 13 Tissue Engineering Market Size, By Region, 2014-2021 (USD Billion)
Table 14 Immunotherapy Market Size, By Region, 2014-2021 (USD Billion)
Table 15 Gene Therapies in Clinical Trials, 2016
Table 16 Gene Therapy Market Size, By Region, 2014-2021 (USD Billion)
Table 17 Number of Clinical Trials for Regenerative Medicine, By Therapeutic Category (2016)
Table 18 Number of Clinical Trials for Regenerative Medicine, By Phase (2016)
Table 19 Market Size, By Application, 2014–2021 (USD Billion)
Table 20 Orthopedic & Musculoskeletal Disorders Market Size, By Region, 2014–2021 (USD Billion)
Table 21 Dermatology Market Size, By Region, 2014–2021 (USD Billion)
Table 22 Cardiology Market Size, By Region, 2014–2021 (USD Billion)
Table 23 Central Nervous System Diseases Market Size, By Region, 2014–2021 (USD Billion)
Table 24 Cancer Patients (Global), By Cancer Type, 2015–2035
Table 25 Oncology Market Size, By Region, 2014–2021 (USD Billion)
Table 26 Diabetes Market Size, By Region, 2014–2021 (USD Billion)
Table 27 Other Applications Market Size, By Region, 2014–2021 (USD Billion)
Table 28 Global Market Size, By Region, 2014–2021 (USD Billion)
Table 29 North America: Market Size, By Country, 2014–2021 (USD Billion)
Table 30 North America: Market Size, By Product, 2014–2021 (USD Billion)
Table 31 North America: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 32 North America: Market Size, By Application, 2014–2021 (USD Billion)
Table 33 North America: Market Size, By Therapy, 2014–2021 (USD Billion)
Table 34 U.S.: Market Size, By Product, 2014–2021 (USD Billion)
Table 35 U.S.: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 36 U.S.: Market Size, By Application, 2014–2021 (USD Billion)
Table 37 U.S.: Market Size, By Therapy, 2014–2021 (USD Billion)
Table 38 Canada: Market Size, By Product, 2014–2021 (USD Billion)
Table 39 Canada: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 40 Canada: Market Size, By Application, 2014–2021 (USD Billion)
Table 41 Canada: Market Size, By Therapy, 2014–2021 (USD Billion)
Table 42 Europe: Market Size, By Country, 2014–2021 (USD Billion)
Table 43 Europe: Market Size, By Product, 2014–2021 (USD Billion)
Table 44 Europe: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 45 Europe: Market Size, By Application, 2014–2021 (USD Billion)
Table 46 Europe: Market Size, By Therapy, 2014–2021 (USD Billion)
Table 47 Germany: Market Size, By Product, 2014–2021 (USD Billion)
Table 48 Germany: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 49 Germany: Market Size, By Application, 2014–2021 (USD Billion)
Table 50 Germany: Market Size, By Therapy, 2014–2021 (USD Billion)
Table 51 U.K.: Market Size, By Product, 2014–2021 (USD Billion)
Table 52 U.K.: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 53 U.K.: Market Size, By Application, 2014–2021 (USD Billion)
Table 54 U.K.: Market Size, By Therapy, 2014–2021 (USD Billion)
Table 55 France: Market Size, By Product, 2014–2021 (USD Billion)
Table 56 France: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 57 France: Market Size, By Application, 2014–2021 (USD Billion)
Table 58 France: Market Size, By Therapy, 2014–2021 (USD Billion)
Table 59 Italy: Market Size, By Product, 2014–2021 (USD Billion)
Table 60 Italy: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 61 Italy: Regenerative Medicine Market Size, By Application, 2014–2021 (USD Billion)
Table 62 Italy: Regenerative Medicine Market Size, By Therapy, 2014–2021 (USD Billion)
Table 63 Spain: Regenerative Medicine Market Size, By Product, 2014–2021 (USD Billion)
Table 64 Spain: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 65 Spain: Regenerative Medicine Market Size, By Application, 2014–2021 (USD Billion)
Table 66 Spain: Regenerative Medicine Market Size, By Therapy, 2014–2021 (USD Billion)
Table 67 RoE: Regenerative Medicine Market Size, By Product, 2014–2021 (USD Billion)
Table 68 RoE: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 69 RoE: Regenerative Medicine Market Size, By Application, 2014–2021 (USD Billion)
Table 70 RoE: Regenerative Medicine Market Size, By Therapy, 2014–2021 (USD Billion)
Table 71 Asia-Pacific: Regenerative Medicine Market Size, By Product, 2014–2021 (USD Billion)
Table 72 Asia: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 73 Asia-Pacific: Regenerative Medicine Market Size, By Application, 2014–2021 (USD Billion)
Table 74 Asia-Pacific: Regenerative Medicine Market Size, By Therapy, 2013–2021 (USD Billion)
Table 75 RoW: Regenerative Medicine Market Size, By Product, 2014–2021 (USD Billion)
Table 76 RoW: Cell-Based Products Market Size, By Type, 2014–2021 (USD Billion)
Table 77 RoW: Regenerative Medicine Market Size, By Application, 2014–2021 (USD Billion)
Table 78 RoW: Regenerative Medicine Market Size, By Therapy, 2014–2021 (USD Billion)
Table 79 Ranking of Major Players in the Global Cell-Based Regenerative Medicine Market (2015)
Table 80 Ranking of Major Players in the Global Acellular Regenerative Medicine Market (2015)
Table 81 Key Products in the Cell-Based Regenerative Medicine Market (2015)
Table 82 Key Products in the Acellular Regenerative Medicine Market (2015)
Table 83 Acquisitions, 2014–2017
Table 84 Partnerships, 2014–2016
Table 85 Regulatory Approvals, 2014–2016
Table 86 New Product Developments, 2013–2016
Table 87 Others, 2014–2016
 
 
List of Figures (38 Figures)
 
Figure 1 Research Design
Figure 2 Market Size Estimation Methodology: Bottom-Up Approach
Figure 3 Market Size Estimation Methodology: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Cell-Based Products to Lead the Market During the Forecast Period
Figure 7 Cell Therapy to Dominate the Regenerative Medicine Market By 2021
Figure 8 Global Regenerative Medicine Market, By Application, 2016 vs 2021
Figure 9 North America to Lead the Regenerative Medicine Market During  the Forecast Period
Figure 10 Global Regenerative Medicine Market to Register High, Double-Digit Growth From 2016 to 2021
Figure 11 Cell Therapy Segment to Dominate the Regenerative Medicine Market in 2016
Figure 12 Asia-Pacific to Be the Fastest-Growing Region in the Forecast Period
Figure 13 Global Regenerative Medicine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 14 Global Regenerative Medicine Market Segmentation, By Product
Figure 15 Cell-Based Products to Command the Largest Share of the Global Regenerative Medicine Market in 2016
Figure 16 Cell-Based Products Market Segmentation, By Type
Figure 17 Cell Therapy to Dominate the Regenerative Medicine Market During the Forecast Period
Figure 18 Orthopedic & Musculoskeletal Disorders Segment to Dominate the Regenerative Medicine Applications Market in 2016
Figure 19 Number of Diabetes Cases, 2015 vs 2040 (Million)
Figure 20 North America: Regenerative Medicine Market Snapshot
Figure 21 North America: Regenerative Medicine Market Size, By Product, 2014–2021 (USD Billion)
Figure 22 U.S.: Regenerative Medicine Market Size, By Product, 2014–2021 (USD Billion)
Figure 23 Europe: Regenerative Medicine Market Snapshot
Figure 24 Europe: Regenerative Medicine Market Size, By Therapy, 2014–2021 (USD Billion)
Figure 25 Germany: Regenerative Medicine Market Size, By Product, 2014–2021 (USD Billion)
Figure 26 Asia-Pacific: Regenerative Medicine Market Snapshot
Figure 27 Asia-Pacific.: Regenerative Medicine Market Size, By Product, 2014–2021 (USD Billion)
Figure 28 Rest of the World: Regenerative Medicine Market Snapshot
Figure 29 RoW: Regenerative Medicine Market Size, By Therapy, 2014–2021 (USD Billion)
Figure 30 Leading Market Players Adopted Both Organic and Inorganic Growth Strategies Over the Last Four Years (2013–2017)
Figure 31 Battle for Market Share: New Product Launches & Product Enhancements are the Key Strategies
Figure 32 Acelity (KCI Licensing): Company Snapshot (2015)
Figure 33 Nuvasive, Inc.: Company Snapshot (2015)
Figure 34 Vericel Corporation: Company Snapshot (2015)
Figure 35 Osiris Therapeutics, Inc.: Company Snapshot (2014)
Figure 36 Integra Lifesciences Corporation: Company Snapshot (2015)
Figure 37 Medtronic PLC: Company Snapshot (2016)
Figure 38 Japan Tissue Engineering Co., Ltd: Company Snapshot (2015)

The global Regenerative medicine market is expected to reach USD 38.70 Billion by 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6% from 2016 to 2021.  This market is segmented based on types, therapy, application, and regions.

A number of factors, such as the government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population are expected to drive the growth of this market. However, entry of new players and product failures and recalls are expected to challenge the market growth.

The global market is segmented into two types, namely, cell-based products and acellular products. The cell-based products segment is expected to account for the largest share in the global market in 2016. The increasing awareness about stem cell therapy, growing funding for new stem cell lines driving the growth of the cell-based products segment in the market.

Based on therapy, the Regenerative medicine market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. Cell therapy segment is expected to account for the largest share in the global market. The key drivers are increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies.

This market is also segmented by application. By application, orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is the fastest growing segment in the market due to increasing incidences of cancer globally and increasing demand for cancer treatments.

Regenerative Medicines Market

The global Regenerative medicine market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centred at China, Japan and India. Increasing research activities in Asian countries, availability of funding for research, and the establishment of biobanks and research centers are some factors propelling market growth.

The key players in the cell-based products segment are Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.). The key players in the acellular products segment are Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo